No Good Organ Wasted
Accunea was founded with a shared belief that real-time biomarker monitoring has the power to reduce organ discard rates and to improve patient outcomes following transplantation.
We believe that our technology can overcome the lack of actionable data at the point-of-care, both pre- and post-transplantation..
​
Accunea seeks to complement and enhance the skills of medical professionals, not to replace them.
We believe that technology best serves patient safety when it gives clinicians novel insights for making critical decisions, such as when to discard a donated organ, or to change a treatment plan.
We achieve this by providing cutting-edge organ health and function monitoring capabilities alongside advanced analytics designed for the specific needs of organ transplantation.
Better Health Outcomes for All
First articulated in the WHO's 1946 Constitution, every human being on the planet has a fundamental right to the highest attainable standard of health.
Here at Accunea we believe that it falls on us as health technology innovators to help realise this goal.
​
We're working towards the United Nations Sustainable Development Goal 3: Ensure healthy lives and promote well-being for all at all ages.
Dialysis significantly impacts the quality of life of patients, and can produce up to 7 tonnes of CO2 per patient per year.
Increasing transplantation rates through improved organ availability will directly benefit patients by improving their quality and quantity of life, and will contribute to lowering the overall carbon footprint of dialysis.
We believe creating a better tomorrow starts with the actions we take today, and we continually strive towards improvement and excellence for the benefit of our customers, colleagues and the world.